Enhabit, Inc.: A Sell Rating Amid Overly Optimistic Growth Expectations and Financial Challenges
TipRanksMar 13 13:56
Enhabit Analyst Ratings
BenzingaMar 11 22:12
Analysts' Opinions Are Mixed on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD) and Enhabit, Inc (EHAB)
TipRanksMar 11 13:20
UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating
MT NewswiresMar 9 00:35
Enhabit, Inc (EHAB) Receives a Rating Update From a Top Analyst
TipRanksMar 7 20:38
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enhabit, Inc (EHAB) and UnitedHealth (UNH)
TipRanksMar 7 18:12
Enhabit Analyst Ratings
BenzingaMar 7 17:52
Enhabit Analyst Ratings
BenzingaMar 6 22:20
TD Cowen Remains a Hold on Enhabit, Inc (EHAB)
TipRanksMar 6 20:36
TD Cowen Initiates Coverage On Enhabit With Market Perform Rating, Announces Price Target of $12
BenzingaDec 12, 2023 21:38
Enhabit Analyst Ratings
BenzingaDec 12, 2023 21:36
Analysts Conflicted on These NA Names: Enhabit, Inc (EHAB) and Forestar Group (FOR)
TipRanksNov 10, 2023 19:21
Weak Performance and High Leverage: Maintaining Sell Rating for Enhabit, Inc
TipRanksOct 3, 2023 20:25
Analysts Conflicted on These NA Names: Enhabit, Inc (EHAB) and Fortrea Holdings Inc. (FTRE)
TipRanksAug 15, 2023 18:40
Goldman Sachs Sticks to Its Hold Rating for Enhabit, Inc (EHAB)
TipRanksAug 14, 2023 20:05
Enhabit Analyst Ratings
BenzingaAug 11, 2023 21:03
Bank of America Securities Remains a Sell on Enhabit, Inc (EHAB)
TipRanksAug 11, 2023 17:05
Enhabit, Inc (EHAB) Gets a Hold From Credit Suisse
TipRanksAug 10, 2023 18:35
Goldman Sachs Adjusts Price Target on Enhabit to $13 From $15, Maintains Neutral Rating
MT NewswiresJul 17, 2023 21:52
Goldman Sachs Maintains Neutral on Enhabit, Lowers Price Target to $13
BenzingaJul 17, 2023 20:09
No Data
No Data